Secondary endpoints are patient-oriented major adverse cardiac event ( MACE ) ( death , myocardial infarction and target-vessel revascularization ) , device-oriented MACE ( cardiac death , myocardial infarction and target-lesion revascularization ) , stent thrombosis according to ARC and binary restenosis at follow-up 12 months angiography .